HomePediatric Hematology/Oncology

Pediatric Hematology/Oncology

Clinical discussions on pediatric blood disorders, childhood cancers, and specialized treatment protocols.

Recent Discussions

How would you manage a young patient with HL who develops HF (EF < 30%) after 4 cycles of A+AVD who obtained a PET2 CR?

2 Answers

Mednet Member

Hematology · The Robert Larner, M.D. College of Medicine at The University of Vermont

This is a tough case, and the management would depend on the extent of disease. Assuming that this is advanced stage HL, given the use of BV+AVD, I would be in favor of completing 6 cycles of therapy with a non-anthracycline-based regimen. You can consider consolidative radiation, but this would nee...

Pediatric Hematology/Oncology

Recent Discussions

How would you manage a young patient with HL who develops HF (EF < 30%) after 4 cycles of A+AVD who obtained a PET2 CR?

Susan E. Creary, MD

Kenneth I. Ataga, MD

Ellis J. Neufeld, MD, PhD

Julia Meade, MD

Peter Newburger, MD

Lindsay Haacker